Seizure drug Qudexy XR approved for use in younger patients

Qudexy XR, a treatment option for seizures, has been approved for an expanded indication that will allow it to be used In patients as young as 2 years old, drug maker Upsher-Smith said on Monday. This treatment already had been approved for patients 10 and up since June 2014. It Is primarily used as a therapeutic measure for patients prone to partial-onset or primary generalized tonic-clonic seizures. The capsules can be ground into a fine powder and sprinkled onto soft food for patients who h Read More »